GlassScriptPhysician profile
Gil Freitas
NPI 1922268275
$12,517.27
in general payments reported to CMS, 2019-2025
7 companies · $848 in 2025
The $848 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,151 · 2023: $4,968 · 2024: $1,550 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,461 · Food and Beverage: $2,163 · Consulting Fee: $1,725 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,461.39 |
| Food and Beverage | $2,163.15 |
| Consulting Fee | $1,725.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,977.79 | 2022-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,714.86 | 2023-2024 | Signia |
| Medical Device Business Services, INC. | $1,483.81 | 2023 | Vistaseal |
| Davol INC. | $707.17 | 2025 | Phasix Mesh |
| Applied Medical Resources Corporation | $375.00 | 2023 | |
| Ethicon US, LLC | $232.39 | 2023-2024 | Echelon Endopath, Vistaseal |
| Hologic Sales and Service, LLC | $26.25 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gil Freitas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.